Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Structure-Based PROTAC Design In-Silico

Project description

Towards the efficient design of protein-targeting drugs

Proteolysis-targeting chimeras (PROTACs) are emerging as promising therapeutic molecules due to their capacity to degrade protein targets. PROTACs consist of a protein-targeting moiety and one that binds an E3 ubiquitin ligase responsible for target protein degradation. Currently, PROTAC design is an empirical process. Scientists of the EU-funded SBPD In-Silico project aim to facilitate PROTAC design based on structure. To achieve this, they will investigate the molecular mechanism by which PROTACs attract protein targets and the E3 ligase to form a complex. This information will be used to expand the available PROTAC molecules, setting the ground for a powerful new therapeutic modality against undruggable targets.

Objective

Proteolysis Targeting Chimeras (PROTACs) are small molecules that induce the degradation of target proteins of interest and have shown considerable promise as novel therapeutic agents. PROTACs are heterobifunctional compounds containing one moiety that binds to the target protein of interest and one that binds to an E3 ubiquitin ligase. Recruitment of the E3 ligase leads to ubiquitination and subsequent degradation of the target by the proteasome. The design of PROTACs largely remains an empirical process because of an insufficient understanding of the molecular basis for productive recruitment of target and E3 ligase into a ternary complex. Furthermore, there are only a handful of small-molecule ligands for E3 ligases that are amenable for PROTAC conjugation, so expanding the chemical space to PROTAC design is an important direction for the field. Virtual screening and structure-based drug design are powerful approaches for designing of drug-like molecules but their application to PROTAC design is still in its infancy. The structural complexity of the ternary complex central to PROTAC activity, and the chemical complexity of PROTAC molecules, are amongst some of the main challenges to structure-based PROTAC design. The goal of this proposal is to develop novel methodologies to contribute to systematically address these important challenges. The long-term goal of this proposal is to develop structure-based PROTAC design as an efficient, universally applicable platform for prediction, designing, and screening of effective PROTAC degraders of target proteins. The success in this project will pave the way to efficiently degrading “undruggable” targets as a powerful new modality of chemical intervention into biology and disease.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2019

See all projects funded under this call

Coordinator

UNIVERSITY OF DUNDEE
Net EU contribution
€ 224 933,76
Address
Nethergate
DD1 4HN Dundee
United Kingdom
Region
Scotland Eastern Scotland Angus and Dundee City
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 224 933,76